中路股份(600818.SH):申萬宏源擬延期至年報披露後再次進行平倉操作
格隆匯4月1日丨中路股份(600818.SH)公佈,公司於2021年3月5日在上海證券交易所網站披露了《中路股份有限公司控股股東集中競價被動減持股份計劃公吿》,申萬宏源證券上海徐彙區龍漕路證券營業部(下稱申萬宏源)擬按照《上市公司股東、董監高減持股份的若干規定》自2021年3月26日起的3個月內,通過證券交易所集中競價的方式減持不超過321.45萬股公司股份(佔公司目前總股本的1%)。
公司於2021年4月1日接到中路集團轉達的《通知函》,根據上海證券交易所《上市公司控股股東、實際控制人行為指引》相關規定,申萬宏源將延期至公司2020年年報披露後,再次進行平倉操作。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.